Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam M Spivak

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Antimicrobial Agents and Chemotherapy|August 15, 2018
Synthetic Ingenols Maximize Protein Kinase C-Induced HIV-1 Latency ReversalAdam M Spivak, Racheal A Nell, Mark Petersen, et al.
Biochemical Pharmacology|November 21, 2021
Histone deacetylase inhibition reduces deleterious cytokine release induced by ingenol stimulationErin T Larragoite, Racheal A Nell, Laura J Martins, et al.
Nature Communications|November 18, 2018
A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferationDaniel B Reeves, Elizabeth R Duke, Thor A Wagner, et al.
Retrovirology|December 22, 2016
Janus kinase inhibition suppresses PKC-induced cytokine release without affecting HIV-1 latency reversal ex vivoAdam M Spivak, Erin T Larragoite, McKenna L Coletti, et al.
Current HIV/AIDS Reports|September 12, 2019
Tyrosine Kinase Inhibition: a New Perspective in the Fight against HIVSara Rodríguez-Mora, Adam M Spivak, Matthew A Szaniawski, et al.
Journal of Clinical & Cellular Immunology|February 6, 2023
Cytokine Deficiencies in Patients with Long-COVIDElizabeth Scp Williams, Thomas B Martins, Kevin S Shah, et al.
Open Forum Infectious Diseases|July 14, 2021
Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple SclerosisElena G Gibson, Melissa Pender, Michael Angerbauer, et al.
Frontiers in Immunology|October 7, 2016
HIV Latency-Reversing Agents Have Diverse Effects on Natural Killer Cell FunctionCarolina Garrido, Adam M Spivak, Natalia Soriano-Sarabia, et al.
AIDS Research and Human Retroviruses|November 26, 2010
Short communication: dynamic constraints on the second phase compartment of HIV-infected cellsAdam M Spivak, S Alireza Rabi, Moira A McMahon, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2013
Uracil DNA glycosylase initiates degradation of HIV-1 cDNA containing misincorporated dUTP and prevents viral integrationAmy F Weil, Devlina Ghosh, Yan Zhou, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|August 15, 2018
Synthetic Ingenols Maximize Protein Kinase C-Induced HIV-1 Latency ReversalAdam M Spivak, Racheal A Nell, Mark Petersen, et al.
Biochemical Pharmacology|November 21, 2021
Histone deacetylase inhibition reduces deleterious cytokine release induced by ingenol stimulationErin T Larragoite, Racheal A Nell, Laura J Martins, et al.
Nature Communications|November 18, 2018
A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferationDaniel B Reeves, Elizabeth R Duke, Thor A Wagner, et al.
Retrovirology|December 22, 2016
Janus kinase inhibition suppresses PKC-induced cytokine release without affecting HIV-1 latency reversal ex vivoAdam M Spivak, Erin T Larragoite, McKenna L Coletti, et al.
Current HIV/AIDS Reports|September 12, 2019
Tyrosine Kinase Inhibition: a New Perspective in the Fight against HIVSara Rodríguez-Mora, Adam M Spivak, Matthew A Szaniawski, et al.
Journal of Clinical & Cellular Immunology|February 6, 2023
Cytokine Deficiencies in Patients with Long-COVIDElizabeth Scp Williams, Thomas B Martins, Kevin S Shah, et al.
Open Forum Infectious Diseases|July 14, 2021
Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple SclerosisElena G Gibson, Melissa Pender, Michael Angerbauer, et al.
Frontiers in Immunology|October 7, 2016
HIV Latency-Reversing Agents Have Diverse Effects on Natural Killer Cell FunctionCarolina Garrido, Adam M Spivak, Natalia Soriano-Sarabia, et al.
AIDS Research and Human Retroviruses|November 26, 2010
Short communication: dynamic constraints on the second phase compartment of HIV-infected cellsAdam M Spivak, S Alireza Rabi, Moira A McMahon, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2013
Uracil DNA glycosylase initiates degradation of HIV-1 cDNA containing misincorporated dUTP and prevents viral integrationAmy F Weil, Devlina Ghosh, Yan Zhou, et al.
Pageof 7